Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The new company name combines the “FUJIFILM” brand, which is recognized worldwide as a global company, together with the “Irvine Scientific” brand
January 2, 2019
By: Betsy Louda
Irvine Scientific Sales Company, a US subsidiary of FUJIFILM Corporation, announced that on January 1, 2019 in the United States, the company changed its name to FUJIFILM Irvine Scientific. The new company name combines the “FUJIFILM” brand, which is recognized worldwide as a global company, together with the “Irvine Scientific” brand, which has been established as a leading company for cell culture media. Under this new company name, FISI will further expand its cell culture media business and accelerate the growth of Fujifilm Group’s bio-medical field through synergies and collaborations. FISI provides a wide range of products including cell culture media for biopharmaceutical production, in vitro fertilization, and cell therapy. The company can develop the optimal custom culture medium to meet the customers’ needs by utilizing its extensive capabilities in quality control, research and development, as well as its proven track record and know-how accumulated over the years. FISI will accelerate the development of high-performance and highly competitive cell culture media solutions by combining its advanced development and manufacturing capabilities with FUJIFILM Group’s bio-related technologies. Also, it will further expand the media business by leveraging FUJIFILM Group’s collective capabilities in the bio-medical field. By developing and providing high-performance cell culture media for biopharmaceutical production, in vitro fertilization, and cell therapy, FISI will contribute to advancing biopharmaceutical development, improving the quality of assisted reproductive technologies, and promoting the commercialization of regenerative medicine.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !